Terminal Secretions

Palliative Care Considerations

• Terminal secretions, or death rattle, is the noise produced by the oscillatory movements of secretions in the upper airways in association with the inspiratory and expiratory phases of respiration.43,44

• As patients lose their ability to swallow and clear oral secretions, accumulation of mucus results in a rattling or gurgling sound produced by air passing through mucus in the lungs and air passages.

• The sound does not represent any discomfort for the patient. However, the sound is sometimes so distressing to the family that it should be treated.

• Terminal secretions are typically seen only in patients who are obtunded or are too weak to expectorate.

• Drugs that decrease secretions are best initiated at the first sign of death rattle, as they do not affect existing respiratory secretions.

• These agents have limited or no impact when the secretions are secondary to pneumonia or pulmonary edema.

Nonpharmacologic Treatment in Palliative Care

• Position the patient on his/her side or in a semiprone position to help facilitate drainage of secretions.

• If necessary, place the patient in the Trendelenburg position (lowering the head of the bed); this allows fluids to move into the oropharnyx, facilitating an easy removal. Do not maintain this position for long, as there is a risk of aspiration.

• Oropharyngeal suctioning is another option, but may be disturbing to both the patient and visitors.

• Fluid intake can also be decreased, as appropriate.

Pharmacotherapy in Palliative Care

• Anticholinergic drugs remain the standard of therapy for prevention and treatment of terminal secretions due to their ability to effectively dry secretions.45-47

• Drugs used for this indication are similar pharmacologically, and one can be selected by anticholinergic potency, onset of action, route of administration, alertness of patient, and cost.

• The most commonly used anticholinergic agents are atropine, hyoscyamine, sco-polamine, and glycopyrrolate.

• Anticholinergic side effects are common and include blurred vision, constipation, urinary retention, confusion, delirium, restlessness, hallucinations, dry mouth, and heart palpitations.

• Unlike the other anticholinergics, glycopyrrolate does not cross the blood-brain barrier and is associated with fewer central nervous system side effects. Gly-

copyrrolate is a potent drying agent when compared to others agents and has the

potential to cause excessive dryness.

Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook

Post a comment